Stayble Therapeutics (Sweden) Probability of Future Stock Price Finishing Over 0.684
| STABL Stock | SEK 0.57 0.02 3.64% |
Stayble |
Stayble Therapeutics Target Price Odds to finish over 0.684
The tendency of Stayble Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over kr 0.68 or more in 90 days |
| 0.57 | 90 days | 0.68 | about 50.0 |
Based on a normal probability distribution, the odds of Stayble Therapeutics to move over kr 0.68 or more in 90 days from now is about 50.0 (This Stayble Therapeutics AB probability density function shows the probability of Stayble Stock to fall within a particular range of prices over 90 days) . Probability of Stayble Therapeutics price to stay between its current price of kr 0.57 and kr 0.68 at the end of the 90-day period is about 39.61 .
Assuming the 90 days trading horizon Stayble Therapeutics has a beta of 0.22. This usually implies as returns on the market go up, Stayble Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Stayble Therapeutics AB will be expected to be much smaller as well. Additionally Stayble Therapeutics AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Stayble Therapeutics Price Density |
| Price |
Predictive Modules for Stayble Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Stayble Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Stayble Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Stayble Therapeutics is not an exception. The market had few large corrections towards the Stayble Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Stayble Therapeutics AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Stayble Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.45 | |
β | Beta against Dow Jones | 0.22 | |
σ | Overall volatility | 0.09 | |
Ir | Information ratio | -0.08 |
Stayble Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Stayble Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Stayble Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Stayble Therapeutics generated a negative expected return over the last 90 days | |
| Stayble Therapeutics has high historical volatility and very poor performance | |
| Stayble Therapeutics has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (12.09 M) with profit before overhead, payroll, taxes, and interest of 9 K. | |
| Stayble Therapeutics AB has accumulated about 42.71 M in cash with (9.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.09, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 33.0% of the company outstanding shares are owned by corporate insiders |
Stayble Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Stayble Stock often depends not only on the future outlook of the current and potential Stayble Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Stayble Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 13.8 M | |
| Cash And Short Term Investments | 37.5 M |
Stayble Therapeutics Technical Analysis
Stayble Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Stayble Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Stayble Therapeutics AB. In general, you should focus on analyzing Stayble Stock price patterns and their correlations with different microeconomic environments and drivers.
Stayble Therapeutics Predictive Forecast Models
Stayble Therapeutics' time-series forecasting models is one of many Stayble Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Stayble Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Stayble Therapeutics
Checking the ongoing alerts about Stayble Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Stayble Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Stayble Therapeutics generated a negative expected return over the last 90 days | |
| Stayble Therapeutics has high historical volatility and very poor performance | |
| Stayble Therapeutics has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (12.09 M) with profit before overhead, payroll, taxes, and interest of 9 K. | |
| Stayble Therapeutics AB has accumulated about 42.71 M in cash with (9.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.09, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 33.0% of the company outstanding shares are owned by corporate insiders |
Additional Tools for Stayble Stock Analysis
When running Stayble Therapeutics' price analysis, check to measure Stayble Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stayble Therapeutics is operating at the current time. Most of Stayble Therapeutics' value examination focuses on studying past and present price action to predict the probability of Stayble Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stayble Therapeutics' price. Additionally, you may evaluate how the addition of Stayble Therapeutics to your portfolios can decrease your overall portfolio volatility.